Evidence map›Paper›PMID 30627576›Full record

ArticleBioMed research international2018

Chlorogenic Acid Functions as a Novel Agonist of PPAR

Shu-Guang Peng, Yi-Lin Pang, Qi Zhu, Jing-He Kang, Ming-Xin Liu, Zheng Wang

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Chemical Composition and Biological Activities ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Plants (Basel, Switzerland) · 2021
    Article
  13. Review
  14. Article
  15. Nutrients · 2020
    Review
  16. Nutrients · 2020
    Article
  17. Therapeutic potential of PPARγ natural agonists in liver diseases.Journal of cellular and molecular medicine · 2020
    Review
  18. Review
  19. Article
  20. Antioxidants (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shu-Guang PengCollege of Bioscience and Biotechnology, Hunan Agricultural University, 410128 Changsha, China.
Yi-Lin PangCollege of Bioscience and Biotechnology, Hunan Agricultural University, 410128 Changsha, China.
Qi ZhuCollege of Bioscience and Biotechnology, Hunan Agricultural University, 410128 Changsha, China.
Jing-He KangKey Laboratory of Agro-Ecological Processes in Subtropical, Institute of Subtropical Agriculture, Chinese Academy of Sciences, Hunan, Changsha 410125, China.
Ming-Xin LiuCollege of Bioscience and Biotechnology, Hunan Agricultural University, 410128 Changsha, China.
Zheng WangCollege of Bioscience and Biotechnology, Hunan Agricultural University, 410128 Changsha, China.ORCID 0000-0001-9159-047X
Hunan Agricultural University · CNChinese Academy of Sciences · CNTobacco Research Institute · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rosiglitazone (RG) is a well-known activator of peroxisome proliferator-activated receptor-gamma (PPAR

Indexed as

3T3-L1 CellsAdipocytesAnimalsCCAAT-Enhancer-Binding Protein-betaCell DifferentiationChlorogenic AcidGene Expression RegulationLipolysisMicePerilipin-1PPAR gammaRosiglitazoneSterol Regulatory Element Binding Protein 1TriglyceridesCCAAT-Enhancer-Binding Protein-betaCebpb protein, mouseChlorogenic AcidPerilipin-1Plin1 protein, mousePPAR gammaRosiglitazoneSrebf1 protein, mouseSterol Regulatory Element Binding Protein 1Triglycerides

Identifiers

PMID30627576
PMCPMC6304673
OpenAlexW2902648931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.